Aart G. Jochemsen
Leiden, ZH 2333ZA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma.
Journal: Melanoma research
Published: July 19, 2023
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 13, 2023
Corrigendum to "Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma" [Eur J Cancer 126 (2020) 93-103].
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 03, 2023
Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma.
Journal: Investigative ophthalmology & visual science
Published: December 14, 2022
Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target.
Journal: Cell death discovery
Published: November 03, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.
Journal: Cancers
Published: July 12, 2022
Novel Treatments of Uveal Melanoma Identified with a Synthetic Lethal CRISPR/Cas9 Screen.
Journal: Cancers
Published: May 27, 2022
Correction to: The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival.
Journal: Oncogene
Published: November 16, 2021
The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival.
Journal: Oncogene
Published: January 26, 2021
Last Updated: 09/26/2026